Included In This Lesson
Outline
What is the Generic Name
RISDIPLAM
What is the Trade Name for RISDIPLAM
EVRYSDI
What is the Indication for RISDIPLAM
- 1 INDICATIONS AND USAGE EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in patients 2 months of age and older. EVRYSDI is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in patients 2 months of age and older. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/